Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.3c00734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Urawadee Rajchakit und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Sciences and The Centre for Green Chemical Science, University of Auckland, Auckland 1142, New Zealand. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Metal Nanoparticles, Anti-Infective Agents. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: University of Auckland.
Abstract (Originalsprache)
New antimicrobials are urgently needed to combat the rising global health concern of antibiotic resistance. Antimicrobial peptides (AMPs) are one of the leading candidates as new antimicrobials since they target bacterial membranes and are therefore less prone to bacterial resistance. However, poor enzymatic stability, high production costs, and toxicity are drawbacks that limit their clinical use. Conjugation of AMPs to gold nanoparticles (NPs) may help to improve enzymatic stability and, thus, their overall antimicrobial efficiency. We did a one-pot synthesis of size-controlled (10 nm) gold NPs selectively conjugated to lipopeptides and determined their antibacterial activity. The conjugates exhibited potent (0.13-1.25 μM) antimicrobial activity against clinical isolates, including Gram-positive methicillin-resistant Staphylococcus aureus (S. aureus) ATCC33593, Gram-negative Escherichia coli (E. coli) CTX-M-14, multidrug-resistant Pseudomonas aeruginosa LESB58 and Acinetobacter baumannii ATCC19606, and showed promising activity (90% inhibition of initial biofilms and 80% reduction of preformed biofilms) against S. aureus and E. coli DH5α biofilms at low micromolar concentrations. The conjugates were stable in rat serum and not toxic to representative mammalian cell lines in vitro (≤64 μM) and in vivo (≤100 μM).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Sciences and The Centre for Green Chemical Science, University of Auckland, Auckland 1142, New Zealand.
- The MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington 6012, New Zealand.
- Auckland Bioengineering Institute, University of Auckland, Auckland 1142, New Zealand.
- Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand.
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
ORCID-Profile: Urawadee Rajchakit, Saurabh Lamba, Jun Lu, Simon Swift, Daniel Pletzer, Vijayalekshmi Sarojini
Förderung
- University of Auckland
Zitieren
APA
Rajchakit, U., Lamba, S., Wang, K., Lyons, N., Lu, J., Swift, S., Pletzer, D., & Sarojini, V. (2024). Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00734
Vancouver
Rajchakit U, Lamba S, Wang K, Lyons N, Lu J, Swift S, et al. Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c00734
BibTeX
@article{Rajchakit2024,
author = {Rajchakit, Urawadee and Lamba, Saurabh and Wang, Kelvin and Lyons, Nikita and Lu, Jun and Swift, Simon and Pletzer, Daniel and Sarojini, Vijayalekshmi},
title = {Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.3c00734}
}
EUVIMED